{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:40:57Z","timestamp":1793137257550,"version":"4.5.0"},"reference-count":200,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T00:00:00Z","timestamp":1426550400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1038\/nrgastro.2015.35","type":"journal-article","created":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T10:39:57Z","timestamp":1426588797000},"page":"231-242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":792,"title":["Alcoholic liver disease: mechanisms of injury and targeted treatment"],"prefix":"10.1038","volume":"12","author":[{"given":"Alexandre","family":"Louvet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Mathurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,17]]},"reference":[{"key":"BFnrgastro201535_CR1","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J. Hepatol. 57, 399\u2013420 (2012).","DOI":"10.1016\/j.jhep.2012.04.004"},{"key":"BFnrgastro201535_CR2","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","volume":"141","author":"B Gao","year":"2011","unstructured":"Gao, B. & Bataller, R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141, 1572\u20131585 (2011).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR3","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1056\/NEJMra0805786","volume":"360","author":"MR Lucey","year":"2009","unstructured":"Lucey, M. R., Mathurin, P. & Morgan, T. R. Alcoholic hepatitis. N. Engl. J. Med. 360, 2758\u20132769 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201535_CR4","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/j.1365-2036.2007.03302.x","volume":"25","author":"P Mathurin","year":"2007","unstructured":"Mathurin, P.  et al. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features. Aliment. Pharmacol. Ther. 25, 1047\u20131054 (2007).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201535_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1034\/j.1600-0676.2003.01804.x","volume":"23","author":"F Pessione","year":"2003","unstructured":"Pessione, F.  et al. Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence. Liver Int. 23, 45\u201353 (2003).","journal-title":"Liver Int."},{"key":"BFnrgastro201535_CR6","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1360-0443.2009.02521.x","volume":"104","author":"C Verrill","year":"2009","unstructured":"Verrill, C., Markham, H., Templeton, A., Carr, N. J. & Sheron, N. Alcohol-related cirrhosis\u2014early abstinence is a key factor in prognosis, even in the most severe cases. Addiction 104, 768\u2013774 (2009).","journal-title":"Addiction"},{"key":"BFnrgastro201535_CR7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/BF02233094","volume":"13","author":"CL Mendenhall","year":"1968","unstructured":"Mendenhall, C. L. Anabolic steroid therapy as an adjunct to diet in alcoholic hepatic steatosis. Am. J. Dig. Dis. 13, 783\u2013791 (1968).","journal-title":"Am. J. Dig. Dis."},{"key":"BFnrgastro201535_CR8","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/S0016-5085(19)33180-4","volume":"63","author":"JT Galambos","year":"1972","unstructured":"Galambos, J. T. Natural history of alcoholic hepatitis. 3. Histological changes. Gastroenterology 63, 1026\u20131035 (1972).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0168-8278(86)80006-X","volume":"2","author":"A Pares","year":"1986","unstructured":"Pares, A., Caballeria, J., Bruguera, M., Torres, M. & Rodes, J. Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. J. Hepatol. 2, 33\u201342 (1986).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003088-200342010-00001","volume":"42","author":"A Norberg","year":"2003","unstructured":"Norberg, A., Jones, A. W., Hahn, R. G. & Gabrielsson, J. L. Role of variability in explaining ethanol pharmacokinetics: research and forensic applications. Clin. Pharmacokinet. 42, 1\u201331 (2003).","journal-title":"Clin. Pharmacokinet."},{"key":"BFnrgastro201535_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.cld.2012.08.002","volume":"16","author":"AI Cederbaum","year":"2012","unstructured":"Cederbaum, A. I. Alcohol metabolism. Clin. Liver Dis. 16, 667\u2013685 (2012).","journal-title":"Clin. Liver Dis."},{"key":"BFnrgastro201535_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev.nutr.20.1.395","volume":"20","author":"CS Lieber","year":"2000","unstructured":"Lieber, C. S. ALCOHOL: its metabolism and interaction with nutrients. Ann. Rev. Nutr. 20, 395\u2013430 (2000).","journal-title":"Ann. Rev. Nutr."},{"key":"BFnrgastro201535_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.alcohol.2004.07.008","volume":"34","author":"CS Lieber","year":"2004","unstructured":"Lieber, C. S. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 34, 9\u201319 (2004).","journal-title":"Alcohol"},{"key":"BFnrgastro201535_CR14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.freeradbiomed.2007.11.004","volume":"44","author":"Y Lu","year":"2008","unstructured":"Lu, Y. & Cederbaum, A. I. CYP2E1 and oxidative liver injury by alcohol. Free Radic. Biol. Med. 44, 723\u2013738 (2008).","journal-title":"Free Radic. Biol. Med."},{"key":"BFnrgastro201535_CR15","first-page":"991","volume":"23","author":"CS Lieber","year":"1999","unstructured":"Lieber, C. S. Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968\u20131998)\u2014a review. Alcohol. Clin. Exp. Res. 23, 991\u20131007 (1999).","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"Suppl. 3","key":"BFnrgastro201535_CR16","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1111\/j.1440-1746.2006.04595.x","volume":"21","author":"AI Cederbaum","year":"2006","unstructured":"Cederbaum, A. I. Cytochrome P450 2E1-dependent oxidant stress and upregulation of anti-oxidant defense in liver cells. J. Gastroenterol. Hepatol. 21 (Suppl. 3), S22\u2013S25 (2006).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro201535_CR17","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/S0891-5849(01)00748-1","volume":"31","author":"MD Wheeler","year":"2001","unstructured":"Wheeler, M. D.  et al. The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radic. Biol. Med. 31, 1544\u20131549 (2001).","journal-title":"Free Radic. Biol. Med."},{"key":"BFnrgastro201535_CR18","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.3748\/wjg.v13.i35.4746","volume":"13","author":"MA Philippe","year":"2007","unstructured":"Philippe, M. A., Ruddell, R. G. & Ramm, G. A. Role of iron in hepatic fibrosis: one piece in the puzzle. World J. Gastroenterol. 13, 4746\u20134754 (2007).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro201535_CR19","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1172\/JCI118077","volume":"96","author":"H Tsukamoto","year":"1995","unstructured":"Tsukamoto, H.  et al. Experimental liver cirrhosis induced by alcohol and iron. J. Clin. Invest. 96, 620\u2013630 (1995).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201535_CR20","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2014.07.018","volume":"147","author":"T Luedde","year":"2014","unstructured":"Luedde, T., Kaplowitz, N. & Schwabe, R. F. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology 147, 765\u2013783 (2014).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jhep.2013.03.033","volume":"59","author":"C Brenner","year":"2013","unstructured":"Brenner, C., Galluzzi, L., Kepp, O. & Kroemer, G. Decoding cell death signals in liver inflammation. J. Hepatol. 59, 583\u2013594 (2013).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR22","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/j.1530-0277.2012.01742.x","volume":"36","author":"A Dolganiuc","year":"2012","unstructured":"Dolganiuc, A., Thomes, P. G., Ding, W. X., Lemasters, J. J. & Donohue, T. M. Jr. Autophagy in alcohol-induced liver diseases. Alcohol. Clin. Exp. Res. 36, 1301\u20131308 (2012).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"BFnrgastro201535_CR23","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1172\/JCI115010","volume":"87","author":"JC Fernandez-Checa","year":"1991","unstructured":"Fernandez-Checa, J. C., Garcia-Ruiz, C., Ookhtens, M. & Kaplowitz, N. Impaired uptake of glutathione by hepatic mitochondria from chronic ethanol-fed rats. Tracer kinetic studies in vitro and in vivo and susceptibility to oxidant stress. J. Clin. Invest. 87, 397\u2013405 (1991).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201535_CR24","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1172\/JCI114008","volume":"83","author":"JC Fernandez-Checa","year":"1989","unstructured":"Fernandez-Checa, J. C., Ookhtens, M. & Kaplowitz, N. Effects of chronic ethanol feeding on rat hepatocytic glutathione. Relationship of cytosolic glutathione to efflux and mitochondrial sequestration. J. Clin. Invest. 83, 1247\u20131252 (1989).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201535_CR25","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/hep.1840160619","volume":"16","author":"T Hirano","year":"1992","unstructured":"Hirano, T., Kaplowitz, N., Tsukamoto, H., Kamimura, S. & Fernandez-Checa, J. C. Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats. Hepatology 16, 1423\u20131427 (1992).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR26","doi-asserted-by":"publisher","first-page":"36664","DOI":"10.1074\/jbc.M105352200","volume":"276","author":"MD Wheeler","year":"2001","unstructured":"Wheeler, M. D.  et al. Overexpression of manganese superoxide dismutase prevents alcohol-induced liver injury in the rat. J. Biol. Chem. 276, 36664\u201336672 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro201535_CR27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1055\/s-2007-1007172","volume":"18","author":"JC Fernandez-Checa","year":"1998","unstructured":"Fernandez-Checa, J. C., Kaplowitz, N., Garcia-Ruiz, C. & Colell, A. Mitochondrial glutathione: importance and transport. Semin. Liver Dis. 18, 389\u2013401 (1998).","journal-title":"Semin. Liver Dis."},{"key":"BFnrgastro201535_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/0741-8329(93)90067-X","volume":"10","author":"JC Fernandez-Checa","year":"1993","unstructured":"Fernandez-Checa, J. C., Hirano, T., Tsukamoto, H. & Kaplowitz, N. Mitochondrial glutathione depletion in alcoholic liver disease. Alcohol 10, 469\u2013475 (1993).","journal-title":"Alcohol"},{"key":"BFnrgastro201535_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.freeradbiomed.2003.10.017","volume":"36","author":"P Gong","year":"2004","unstructured":"Gong, P., Cederbaum, A. I. & Nieto, N. Heme oxygenase-1 protects HepG2 cells against cytochrome P450 2E1-dependent toxicity. Free Radic. Biol. Med. 36, 307\u2013318 (2004).","journal-title":"Free Radic. Biol. Med."},{"key":"BFnrgastro201535_CR30","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.jhep.2012.06.018","volume":"57","author":"D Imrie","year":"2012","unstructured":"Imrie, D. & Sadler, K. C. Stress management: how the unfolded protein response impacts fatty liver disease. J. Hepatol. 57, 1147\u20131151 (2012).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR31","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jhep.2010.11.005","volume":"54","author":"H Malhi","year":"2011","unstructured":"Malhi, H. & Kaufman, R. J. Endoplasmic reticulum stress in liver disease. J. Hepatol. 54, 795\u2013809 (2011).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR32","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/hep.20309","volume":"40","author":"C Ji","year":"2004","unstructured":"Ji, C., Deng, Q. & Kaplowitz, N. Role of TNF-\u03b1 in ethanol-induced hyperhomocysteinemia and murine alcoholic liver injury. Hepatology 40, 442\u2013451 (2004).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR33","doi-asserted-by":"publisher","first-page":"16544","DOI":"10.1073\/pnas.1308331110","volume":"110","author":"J Petrasek","year":"2013","unstructured":"Petrasek, J.  et al. STING\u2013IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease. Proc. Natl Acad. Sci. USA 110, 16544\u201316549 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201535_CR34","first-page":"G54","volume":"289","author":"F Esfandiari","year":"2005","unstructured":"Esfandiari, F., Villanueva, J. A., Wong, D. H., French, S. W. & Halsted, C. H. Chronic ethanol feeding and folate deficiency activate hepatic endoplasmic reticulum stress pathway in micropigs. Am. J. Physiol. 289, G54\u2013G63 (2005).","journal-title":"Am. J. Physiol."},{"issue":"Suppl. 1","key":"BFnrgastro201535_CR35","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1111\/j.1440-1746.2007.05276.x","volume":"23","author":"C Ji","year":"2008","unstructured":"Ji, C. Dissection of endoplasmic reticulum stress signaling in alcoholic and non-alcoholic liver injury. J. Gastroenterol. Hepatol. 23 (Suppl. 1), S16\u2013S24 (2008).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"Suppl. 3","key":"BFnrgastro201535_CR36","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1111\/j.1440-1746.2006.04582.x","volume":"21","author":"DW Crabb","year":"2006","unstructured":"Crabb, D. W. & Liangpunsakul, S. Alcohol and lipid metabolism. J. Gastroenterol. Hepatol. 21 (Suppl. 3), S56\u2013S60 (2006).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro201535_CR37","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/S0016-5085(03)00276-2","volume":"124","author":"C Ji","year":"2003","unstructured":"Ji, C. & Kaplowitz, N. Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 124, 1488\u20131499 (2003).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR38","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jhep.2013.02.016","volume":"59","author":"V Hernandez-Gea","year":"2013","unstructured":"Hernandez-Gea, V.  et al. Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy. J. Hepatol. 59, 98\u2013104 (2013).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR39","doi-asserted-by":"publisher","first-page":"29342","DOI":"10.1074\/jbc.M202411200","volume":"277","author":"M You","year":"2002","unstructured":"You, M., Fischer, M., Deeg, M. A. & Crabb, D. W. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J. Biol. Chem. 277, 29342\u201329347 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro201535_CR40","first-page":"614","volume":"232","author":"M Endo","year":"2007","unstructured":"Endo, M., Masaki, T., Seike, M. & Yoshimatsu, H. TNF-\u03b1 induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c). Exp. Biol. Med (Maywood) 232, 614\u2013621 (2007).","journal-title":"Exp. Biol. Med (Maywood)"},{"key":"BFnrgastro201535_CR41","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1074\/jbc.273.9.5053","volume":"273","author":"JF Lawler Jr","year":"1998","unstructured":"Lawler, J. F. Jr, Yin, M., Diehl, A. M., Roberts, E. & Chatterjee, S. Tumor necrosis factor-\u03b1 stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neutral sphingomyelinase. J. Biol. Chem. 273, 5053\u20135059 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro201535_CR42","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/hep.20399","volume":"40","author":"T Nakajima","year":"2004","unstructured":"Nakajima, T.  et al. Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage. Hepatology 40, 972\u2013980 (2004).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1074\/jbc.M008791200","volume":"276","author":"A Galli","year":"2001","unstructured":"Galli, A., Pinaire, J., Fischer, M., Dorris, R. & Crabb, D. W. The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor \u03b1 is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver. J. Biol. Chem. 276, 68\u201375 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro201535_CR44","doi-asserted-by":"publisher","first-page":"27997","DOI":"10.1074\/jbc.M302140200","volume":"278","author":"M Fischer","year":"2003","unstructured":"Fischer, M., You, M., Matsumoto, M. & Crabb, D. W. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J. Biol. Chem. 278, 27997\u201328004 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro201535_CR45","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1152\/ajpendo.90412.2008","volume":"295","author":"PE Molina","year":"2008","unstructured":"Molina, P. E. Alcohol\u2013intoxicating roadblocks and bottlenecks in hepatic protein and lipid metabolism. Am. J. Physiol. Endocrinol. Metab. 295, E1\u2013E2 (2008).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrgastro201535_CR46","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou, G.  et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167\u20131174 (2001).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201535_CR47","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.biochi.2007.09.019","volume":"90","author":"J Garcia-Villafranca","year":"2008","unstructured":"Garcia-Villafranca, J., Guillen, A. & Castro, J. Ethanol consumption impairs regulation of fatty acid metabolism by decreasing the activity of AMP-activated protein kinase in rat liver. Biochimie 90, 460\u2013466 (2008).","journal-title":"Biochimie"},{"key":"BFnrgastro201535_CR48","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1152\/ajpcell.00559.2003","volume":"287","author":"M You","year":"2004","unstructured":"You, M. & Crabb, D. W. Recent advances in alcoholic liver disease. I. Minireview: molecular mechanisms of alcoholic fatty liver. Am. J. Physiol. 287, G1\u2013G6 (2004).","journal-title":"Am. J. Physiol."},{"key":"BFnrgastro201535_CR49","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1053\/j.gastro.2013.11.008","volume":"146","author":"H Yin","year":"2014","unstructured":"Yin, H.  et al. Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver. Gastroenterology 146, 801\u2013811 (2014).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR50","first-page":"G892","volume":"294","author":"M You","year":"2008","unstructured":"You, M., Liang, X., Ajmo, J. M. & Ness, G. C. Involvement of mammalian sirtuin 1 in the action of ethanol in the liver. Am. J. Physiol. 294, G892\u2013G898 (2008).","journal-title":"Am. J. Physiol."},{"key":"BFnrgastro201535_CR51","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cmet.2007.12.007","volume":"7","author":"WI Jeong","year":"2008","unstructured":"Jeong, W. I.  et al. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell. Metab. 7, 227\u2013235 (2008).","journal-title":"Cell. Metab."},{"key":"BFnrgastro201535_CR52","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/hep.24524","volume":"54","author":"A Louvet","year":"2011","unstructured":"Louvet, A.  et al. Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice. Hepatology 54, 1217\u20131226 (2011).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR53","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jhep.2006.11.020","volume":"46","author":"I Bykov","year":"2007","unstructured":"Bykov, I.  et al. Hepatic gene expression and lipid parameters in complement C3\u2212\/\u2212 mice that do not develop ethanol-induced steatosis. J. Hepatol. 46, 907\u2013914 (2007).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR54","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1053\/j.gastro.2010.04.041","volume":"139","author":"JI Cohen","year":"2010","unstructured":"Cohen, J. I., Roychowdhury, S., McMullen, M. R., Stavitsky, A. B. & Nagy, L. E. Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice. Gastroenterology 139, 664\u2013674. (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR55","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1053\/j.gastro.2007.01.053","volume":"132","author":"MT Pritchard","year":"2007","unstructured":"Pritchard, M. T.  et al. Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. Gastroenterology 132, 1117\u20131126 (2007).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR56","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1053\/j.gastro.2003.12.008","volume":"126","author":"K Tomita","year":"2004","unstructured":"Tomita, K.  et al. Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met. Gastroenterology 126, 873\u2013885 (2004).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR57","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jhep.2010.01.029","volume":"52","author":"S Naveau","year":"2010","unstructured":"Naveau, S.  et al. Harmful effect of adipose tissue on liver lesions in patients with alcoholic liver disease. J. Hepatol. 52, 895\u2013902 (2010).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR58","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/hep.510250120","volume":"25","author":"S Naveau","year":"1997","unstructured":"Naveau, S. Excess weight risk factor for alcoholic liver disease. Hepatology 25, 108\u2013111 (1997).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR59","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1053\/jhep.2002.31782","volume":"35","author":"B Raynard","year":"2002","unstructured":"Raynard, B.  et al. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 35, 635\u2013638 (2002).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR60","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jhep.2012.03.024","volume":"57","author":"W Dunn","year":"2012","unstructured":"Dunn, W.  et al. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). J. Hepatol. 57, 384\u2013391 (2012).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR61","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/j.1530-0277.2007.00452.x","volume":"31","author":"L Kang","year":"2007","unstructured":"Kang, L.  et al. Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines. Alcohol. Clin. Exp. Res. 31, 1581\u20131588 (2007).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"BFnrgastro201535_CR62","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1172\/JCI200317797","volume":"112","author":"A Xu","year":"2003","unstructured":"Xu, A.  et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J. Clin. Invest. 112, 91\u2013100 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201535_CR63","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/nm788","volume":"8","author":"T Yamauchi","year":"2002","unstructured":"Yamauchi, T.  et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8, 1288\u20131295 (2002).","journal-title":"Nat. Med."},{"key":"BFnrgastro201535_CR64","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/hep.20821","volume":"42","author":"M You","year":"2005","unstructured":"You, M., Considine, R. V., Leone, T. C., Kelly, D. P. & Crabb, D. W. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology 42, 568\u2013577 (2005).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR65","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/hep.22074","volume":"47","author":"Z Song","year":"2008","unstructured":"Song, Z., Zhou, Z., Deaciuc, I., Chen, T. & McClain, C. J. Inhibition of adiponectin production by homocysteine: a potential mechanism for alcoholic liver disease. Hepatology 47, 867\u2013879 (2008).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR66","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1053\/jhep.2000.19621","volume":"32","author":"P Mathurin","year":"2000","unstructured":"Mathurin, P.  et al. Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology 32, 1008\u20131017 (2000).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR67","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S0168-8278(00)80242-1","volume":"32","author":"A Parlesak","year":"2000","unstructured":"Parlesak, A., Schafer, C., Schutz, T., Bode, J. C. & Bode, C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J. Hepatol. 32, 742\u2013747 (2000).","journal-title":"J. Hepatol."},{"issue":"8 Suppl.","key":"BFnrgastro201535_CR68","doi-asserted-by":"publisher","first-page":"75S","DOI":"10.1111\/j.1530-0277.2002.tb02707.x","volume":"26","author":"H Tamai","year":"2002","unstructured":"Tamai, H., Horie, Y., Kato, S., Yokoyama, H. & Ishii, H. Long-term ethanol feeding enhances susceptibility of the liver to orally administered lipopolysaccharides in rats. Alcohol. Clin. Exp. Res. 26 (8 Suppl.) 75S\u201380S (2002).","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"4 Suppl.","key":"BFnrgastro201535_CR69","doi-asserted-by":"publisher","first-page":"48S","DOI":"10.1111\/j.1530-0277.2000.tb00012.x","volume":"24","author":"M Fujimoto","year":"2000","unstructured":"Fujimoto, M.  et al. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance. Alcohol. Clin. Exp. Res. 24 (4 Suppl.) 48S\u201354S (2000).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"BFnrgastro201535_CR70","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/alcalc\/33.6.606","volume":"33","author":"C Hanck","year":"1998","unstructured":"Hanck, C., Rossol, S., Bocker, U., Tokus, M. & Singer, M. V. Presence of plasma endotoxin is correlated with tumour necrosis factor receptor levels and disease activity in alcoholic cirrhosis. Alcohol Alcohol. 33, 606\u2013608 (1998).","journal-title":"Alcohol Alcohol."},{"key":"BFnrgastro201535_CR71","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/path.1711520107","volume":"152","author":"BS Bhagwandeen","year":"1987","unstructured":"Bhagwandeen, B. S., Apte, M., Manwarring, L. & Dickeson, J. Endotoxin induced hepatic necrosis in rats on an alcohol diet. J. Pathol. 152, 47\u201353 (1987).","journal-title":"J. Pathol."},{"key":"BFnrgastro201535_CR72","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/0016-5085(95)90027-6","volume":"108","author":"Y Adachi","year":"1995","unstructured":"Adachi, Y., Moore, L. E., Bradford, B. U., Gao, W. & Thurman, R. G. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108, 218\u2013224 (1995).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR73","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3181\/00379727-205-43703","volume":"205","author":"AA Nanji","year":"1994","unstructured":"Nanji, A. A., Khettry, U. & Sadrzadeh, S. M. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc. Soc. Exp. Biol Med. 205, 243\u2013247 (1994).","journal-title":"Proc. Soc. Exp. Biol Med."},{"key":"BFnrgastro201535_CR74","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/hep.21138","volume":"43","author":"T Gustot","year":"2006","unstructured":"Gustot, T.  et al. Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology 43, 989\u20131000 (2006).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR75","doi-asserted-by":"publisher","first-page":"7628","DOI":"10.4049\/jimmunol.176.12.7628","volume":"176","author":"S Oak","year":"2006","unstructured":"Oak, S., Mandrekar, P., Catalano, D., Kodys, K. & Szabo, G. TLR2- and TLR4-mediated signals determine attenuation or augmentation of inflammation by acute alcohol in monocytes. J. Immunol. 176, 7628\u20137635 (2006).","journal-title":"J. Immunol."},{"key":"BFnrgastro201535_CR76","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0898-6568(00)00149-2","volume":"13","author":"M Guha","year":"2001","unstructured":"Guha, M. & Mackman, N. LPS induction of gene expression in human monocytes. Cell. Signal. 13, 85\u201394 (2001).","journal-title":"Cell. Signal."},{"key":"BFnrgastro201535_CR77","doi-asserted-by":"publisher","first-page":"8435","DOI":"10.1074\/jbc.M212076200","volume":"278","author":"MD Wheeler","year":"2003","unstructured":"Wheeler, M. D. & Thurman, R. G. Up-regulation of CD14 in liver caused by acute ethanol involves oxidant-dependent AP-1 pathway. J. Biol. Chem. 278, 8435\u20138441 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro201535_CR78","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/hep.22470","volume":"48","author":"I Hritz","year":"2008","unstructured":"Hritz, I.  et al. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology 48, 1224\u20131231 (2008).","journal-title":"Hepatology"},{"issue":"11 Suppl.","key":"BFnrgastro201535_CR79","doi-asserted-by":"publisher","first-page":"110S","DOI":"10.1097\/01.alc.0000189288.30358.4b","volume":"29","author":"T Zima","year":"2005","unstructured":"Zima, T. & Kalousova, M. Oxidative stress and signal transduction pathways in alcoholic liver disease. Alcohol. Clin. Exp. Res. 29 (11 Suppl.) 110S\u2013115S (2005).","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"Suppl. 1","key":"BFnrgastro201535_CR80","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1111\/j.1440-1746.2007.05277.x","volume":"23","author":"S De Minicis","year":"2008","unstructured":"De Minicis, S. & Brenner, D. A. Oxidative stress in alcoholic liver disease: role of NADPH oxidase complex. J. Gastroenterol. Hepatol. 23 (Suppl. 1) S98\u2013S103 (2008).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro201535_CR81","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1053\/jhep.2001.25350","volume":"34","author":"T Uesugi","year":"2001","unstructured":"Uesugi, T., Froh, M., Arteel, G. E., Bradford, B. U. & Thurman, R. G. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 34, 101\u2013108 (2001).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR82","first-page":"G512","volume":"295","author":"S Xiong","year":"2008","unstructured":"Xiong, S.  et al. Hepatic macrophage iron aggravates experimental alcoholic steatohepatitis. Am. J. Physiol. 295, G512\u2013G521 (2008).","journal-title":"Am. J. Physiol."},{"key":"BFnrgastro201535_CR83","first-page":"G1355","volume":"272","author":"M Lin","year":"1997","unstructured":"Lin, M., Rippe, R. A., Niemela, O., Brittenham, G. & Tsukamoto, H. Role of iron in NF-kappa B activation and cytokine gene expression by rat hepatic macrophages. Am. J. Physiol. 272, G1355\u2013G1364 (1997).","journal-title":"Am. J. Physiol."},{"key":"BFnrgastro201535_CR84","first-page":"G719","volume":"283","author":"H She","year":"2002","unstructured":"She, H.  et al. Iron activates NF-kappaB in Kupffer cells. Am. J. Physiol. 283, G719\u2013G726 (2002).","journal-title":"Am. J. Physiol."},{"key":"BFnrgastro201535_CR85","first-page":"G1240","volume":"277","author":"H Tsukamoto","year":"1999","unstructured":"Tsukamoto, H.  et al. Iron primes hepatic macrophages for NF-kappaB activation in alcoholic liver injury. Am. J. Physiol. 277, G1240\u2013G1250 (1999).","journal-title":"Am. J. Physiol."},{"key":"BFnrgastro201535_CR86","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/(SICI)1096-9896(199809)186:1<82::AID-PATH151>3.0.CO;2-D","volume":"186","author":"SC Afford","year":"1998","unstructured":"Afford, S. C.  et al. Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis. J. Pathol. 186, 82\u201389 (1998).","journal-title":"J. Pathol."},{"key":"BFnrgastro201535_CR87","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1053\/j.gastro.2006.12.036","volume":"132","author":"J Colmenero","year":"2007","unstructured":"Colmenero, J.  et al. Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. Gastroenterology 132, 687\u2013697 (2007).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR88","first-page":"1156","volume":"24","author":"J Maltby","year":"1996","unstructured":"Maltby, J., Wright, S., Bird, G. & Sheron, N. Chemokine levels in human liver homogenates: associations between GRO alpha and histopathological evidence of alcoholic hepatitis. Hepatology 24, 1156\u20131160 (1996).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR89","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0168-8278(00)80219-6","volume":"32","author":"J Taieb","year":"2000","unstructured":"Taieb, J.  et al. Blood neutrophil functions and cytokine release in severe alcoholic hepatitis: effect of corticosteroids. J. Hepatol. 32, 579\u2013586 (2000).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR90","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/hep.26169","volume":"57","author":"MA Barnes","year":"2013","unstructured":"Barnes, M. A.  et al. Macrophage migration inhibitory factor contributes to ethanol-induced liver injury by mediating cell injury, steatohepatitis, and steatosis. Hepatology 57, 1980\u20131991 (2013).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR91","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1002\/hep.24599","volume":"54","author":"P Mandrekar","year":"2011","unstructured":"Mandrekar, P., Ambade, A., Lim, A., Szabo, G. & Catalano, D. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice. Hepatology 54, 2185\u20132197 (2011).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR92","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/hep.26607","volume":"59","author":"J Wan","year":"2014","unstructured":"Wan, J.  et al. M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology 59, 130\u2013142 (2014).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR93","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jhep.2012.09.016","volume":"58","author":"JS Byun","year":"2013","unstructured":"Byun, J. S., Suh, Y. G., Yi, H. S., Lee, Y. S. & Jeong, W. I. Activation of Toll-like receptor 3 attenuates alcoholic liver injury by stimulating Kupffer cells and stellate cells to produce interleukin-10 in mice. J. Hepatol. 58, 342\u2013349 (2013).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR94","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1053\/j.gastro.2004.01.022","volume":"126","author":"M Minagawa","year":"2004","unstructured":"Minagawa, M., Deng, Q., Liu, Z. X., Tsukamoto, H. & Dennert, G. Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption. Gastroenterology 126, 1387\u20131399 (2004).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR95","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1530-0277.2008.00842.x","volume":"33","author":"G Szabo","year":"2009","unstructured":"Szabo, G. & Mandrekar, P. A recent perspective on alcohol, immunity, and host defense. Alcohol. Clin. Exp. Res. 33, 220\u2013232 (2009).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"BFnrgastro201535_CR96","first-page":"G571","volume":"289","author":"P Brun","year":"2005","unstructured":"Brun, P., Castagliuolo, I., Pinzani, M., Palu, G. & Martines, D. Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. Am. J. Physiol. 289, G571\u2013G578 (2005).","journal-title":"Am. J. Physiol."},{"key":"BFnrgastro201535_CR97","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1053\/jhep.2003.50182","volume":"37","author":"YH Paik","year":"2003","unstructured":"Paik, Y. H.  et al. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37, 1043\u20131055 (2003).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR98","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/jcp.20366","volume":"204","author":"C Thirunavukkarasu","year":"2005","unstructured":"Thirunavukkarasu, C., Uemura, T., Wang, L. F., Watkins, S. C. & Gandhi, C. R. Normal rat hepatic stellate cells respond to endotoxin in LBP-independent manner to produce inhibitor(s) of DNA synthesis in hepatocytes. J. Cell. Physiol. 204, 654\u2013665 (2005).","journal-title":"J. Cell. Physiol."},{"key":"BFnrgastro201535_CR99","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/hep.24018","volume":"53","author":"AW Yan","year":"2011","unstructured":"Yan, A. W.  et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 53, 96\u2013105 (2011).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR100","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1111\/j.1530-0277.2009.01022.x","volume":"33","author":"E Mutlu","year":"2009","unstructured":"Mutlu, E.  et al. Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. Alcohol. Clin. Exp. Res. 33, 1836\u20131846 (2009).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"BFnrgastro201535_CR101","doi-asserted-by":"publisher","unstructured":"Chen, P., Starkel, P., Turner, J. R., Ho, S. B. & Schnabl, B. Dysbiosis-induced intestinal inflammation activates tumor necrosis factor I and mediates alcoholic liver disease in mice. Hepatology \n                    http:\/\/dx.doi.org\/10.1002\/hep.27489\n                    \n                  .","DOI":"10.1002\/hep.27489"},{"key":"BFnrgastro201535_CR102","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","volume":"146","author":"B Schnabl","year":"2014","unstructured":"Schnabl, B. & Brenner, D. A. Interactions between the intestinal microbiome and liver diseases. Gastroenterology 146, 1513\u20131524 (2014).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR103","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1053\/j.gastro.2014.09.014","volume":"148","author":"P Chen","year":"2014","unstructured":"Chen, P.  et al. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. Gastroenterology 148, 203\u2013214 (2014).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR104","doi-asserted-by":"publisher","first-page":"G966","DOI":"10.1152\/ajpcell.00001.2012","volume":"302","author":"EA Mutlu","year":"2012","unstructured":"Mutlu, E. A.  et al. Colonic microbiome is altered in alcoholism. Am. J. Physiol. 302, G966\u2013G978 (2012).","journal-title":"Am. J. Physiol."},{"key":"BFnrgastro201535_CR105","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature13568","volume":"513","author":"N Qin","year":"2014","unstructured":"Qin, N.  et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 513, 59\u201364 (2014).","journal-title":"Nature"},{"key":"BFnrgastro201535_CR106","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.alcohol.2008.12.009","volume":"43","author":"CB Forsyth","year":"2009","unstructured":"Forsyth, C. B.  et al. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol 43, 163\u2013172 (2009).","journal-title":"Alcohol"},{"key":"BFnrgastro201535_CR107","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jhep.2008.02.015","volume":"48","author":"V Stadlbauer","year":"2008","unstructured":"Stadlbauer, V.  et al. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J. Hepatol. 48, 945\u2013951 (2008).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR108","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.alcohol.2008.08.006","volume":"42","author":"IA Kirpich","year":"2008","unstructured":"Kirpich, I. A.  et al. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol 42, 675\u2013682 (2008).","journal-title":"Alcohol"},{"key":"BFnrgastro201535_CR109","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrendo.2011.126","volume":"7","author":"NM Delzenne","year":"2011","unstructured":"Delzenne, N. M., Neyrinck, A. M., Backhed, F. & Cani, P. D. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat. Rev. Endocrinol. 7, 639\u2013646 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"key":"BFnrgastro201535_CR110","doi-asserted-by":"publisher","first-page":"16639","DOI":"10.3748\/wjg.v20.i44.16639","volume":"20","author":"G Malaguarnera","year":"2014","unstructured":"Malaguarnera, G., Giordano, M., Nunnari, G., Bertino, G. & Malaguarnera, M. Gut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectives. World J. Gastroenterol. 20, 16639\u201316648 (2014).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro201535_CR111","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1152\/ajpcell.00102.2004","volume":"288","author":"AM Diehl","year":"2005","unstructured":"Diehl, A. M. Recent events in alcoholic liver disease, V. effects of ethanol on liver regeneration. Am. J. Physiol. 288, G1\u2013G6 (2005).","journal-title":"Am. J. Physiol."},{"key":"BFnrgastro201535_CR112","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.biocel.2009.09.014","volume":"43","author":"GK Michalopoulos","year":"2011","unstructured":"Michalopoulos, G. K. Liver regeneration: alternative epithelial pathways. Int. J. Biochem. Cell Biol. 43, 173\u2013179 (2011).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"BFnrgastro201535_CR113","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/hep.22335","volume":"48","author":"BD Cosgrove","year":"2008","unstructured":"Cosgrove, B. D.  et al. An inducible autocrine cascade regulates rat hepatocyte proliferation and apoptosis responses to tumor necrosis factor-alpha. Hepatology 48, 276\u2013288 (2008).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR114","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/hep.26538","volume":"58","author":"J Freimuth","year":"2013","unstructured":"Freimuth, J.  et al. Loss of caspase-8 in hepatocytes accelerates the onset of liver regeneration in mice through premature nuclear factor kappa B activation. Hepatology 58, 1779\u20131789 (2013).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR115","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/hep.23430","volume":"51","author":"H Wang","year":"2010","unstructured":"Wang, H.  et al. Interplay of hepatic and myeloid signal transducer and activator of transcription 3 in facilitating liver regeneration via tempering innate immunity. Hepatology 51, 1354\u20131362 (2010).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR116","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/hep.510280509","volume":"28","author":"EM Webber","year":"1998","unstructured":"Webber, E. M., Bruix, J., Pierce, R. H. & Fausto, N. Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology 28, 1226\u20131234 (1998).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR117","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/hep.27447","volume":"61","author":"MJ Xu","year":"2015","unstructured":"Xu, M. J.  et al. Liver is the major source of elevated serum lipocalin-2 levels after bacterial infection or partial hepatectomy: a critical role for IL-6\/STAT3. Hepatology 61, 692\u2013702 (2015).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR118","first-page":"1301","volume":"163","author":"T Roskams","year":"2003","unstructured":"Roskams, T.  et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am. J. Physiol. 163, 1301\u20131311 (2003).","journal-title":"Am. J. Physiol."},{"key":"BFnrgastro201535_CR119","doi-asserted-by":"publisher","first-page":"13037","DOI":"10.1074\/jbc.M101632200","volume":"277","author":"A Koteish","year":"2002","unstructured":"Koteish, A., Yang, S., Lin, H., Huang, X. & Diehl, A. M. Chronic ethanol exposure potentiates lipopolysaccharide liver injury despite inhibiting Jun N-terminal kinase and caspase 3 activation. J. Biol. Chem. 277, 13037\u201313044 (2002).","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 1","key":"BFnrgastro201535_CR120","doi-asserted-by":"publisher","first-page":"E59","DOI":"10.1111\/j.1530-0277.2012.01852.x","volume":"37","author":"RP Dippold","year":"2013","unstructured":"Dippold, R. P., Vadigepalli, R., Gonye, G. E., Patra, B. & Hoek, J. B. Chronic ethanol feeding alters miRNA expression dynamics during liver regeneration. Alcohol. Clin. Exp. Res. 37 (Suppl. 1) E59\u2013E69 (2013).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"BFnrgastro201535_CR121","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1053\/j.gastro.2008.02.022","volume":"134","author":"Y Jung","year":"2008","unstructured":"Jung, Y.  et al. Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans. Gastroenterology 134, 1532\u20131543 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR122","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1002\/hep.25614","volume":"55","author":"P Sancho-Bru","year":"2012","unstructured":"Sancho-Bru, P.  et al. Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis. Hepatology 55, 1931\u20131941 (2012).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR123","unstructured":"Dubuquoy, L.  et al. Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis. Gut (in press)."},{"key":"BFnrgastro201535_CR124","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/hep.25641","volume":"56","author":"M Tsuchiya","year":"2012","unstructured":"Tsuchiya, M.  et al. Interstrain differences in liver injury and one-carbon metabolism in alcohol-fed mice. Hepatology 56, 130\u2013139 (2012).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR125","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1172\/JCI105200","volume":"44","author":"CS Lieber","year":"1965","unstructured":"Lieber, C. S., Jones, D. P. & Decarli, L. M. Effects of prolonged ethanol intake: production of fatty liver despite adequate diets. J. Clin. Invest. 44, 1009\u20131021 (1965).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201535_CR126","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/hep.1840100417","volume":"10","author":"CS Lieber","year":"1989","unstructured":"Lieber, C. S., DeCarli, L. M. & Sorrell, M. F. Experimental methods of ethanol administration. Hepatology 10, 501\u2013510 (1989).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR127","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/hep.1840050212","volume":"5","author":"H Tsukamoto","year":"1985","unstructured":"Tsukamoto, H.  et al. Severe and progressive steatosis and focal necrosis in rat liver induced by continuous intragastric infusion of ethanol and low fat diet. Hepatology 5, 224\u2013232 (1985).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR128","first-page":"R595","volume":"247","author":"H Tsukamoto","year":"1984","unstructured":"Tsukamoto, H., Reidelberger, R. D., French, S. W. & Largman, C. Long-term cannulation model for blood sampling and intragastric infusion in the rat. Am. J. Physiol. 247, R595\u2013R599 (1984).","journal-title":"Am. J. Physiol."},{"key":"BFnrgastro201535_CR129","doi-asserted-by":"publisher","first-page":"G1227","DOI":"10.1152\/ajpcell.00328.2007","volume":"294","author":"C von Montfort","year":"2008","unstructured":"von Montfort, C., Beier, J. I., Guo, L., Kaiser, J. P. & Arteel, G. E. Contribution of the sympathetic hormone epinephrine to the sensitizing effect of ethanol on LPS-induced liver damage in mice. Am. J. Physiol. 294, G1227\u2013G1234 (2008).","journal-title":"Am. J. Physiol."},{"key":"BFnrgastro201535_CR130","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/hep.26419","volume":"58","author":"A Bertola","year":"2013","unstructured":"Bertola, A., Park, O. & Gao, B. Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin. Hepatology 58, 1814\u20131823 (2013).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR131","doi-asserted-by":"publisher","first-page":"G819","DOI":"10.1152\/ajpcell.00168.2013","volume":"306","author":"S Mathews","year":"2014","unstructured":"Mathews, S., Xu, M., Wang, H., Bertola, A. & Gao, B. Animals models of gastrointestinal and liver diseases. Animal models of alcohol-induced liver disease: pathophysiology, translational relevance, and challenges. Am. J. Physiol. 306, G819\u2013G823 (2014).","journal-title":"Am. J. Physiol."},{"key":"BFnrgastro201535_CR132","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/gutjnl-2011-301146","volume":"62","author":"S Affo","year":"2013","unstructured":"Affo, S.  et al. Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis. Gut 62, 452\u2013460 (2013).","journal-title":"Gut"},{"key":"BFnrgastro201535_CR133","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1053\/j.gastro.2014.01.018","volume":"146","author":"J Altamirano","year":"2014","unstructured":"Altamirano, J.  et al. A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology 146, 1231\u20131239 (2014).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR134","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1136\/gutjnl-2013-306098","volume":"63","author":"S Affo","year":"2014","unstructured":"Affo, S.  et al. CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis. Gut 63, 1782\u20131792 (2014).","journal-title":"Gut"},{"key":"BFnrgastro201535_CR135","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","volume":"136","author":"M Dominguez","year":"2009","unstructured":"Dominguez, M.  et al. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. Gastroenterology 136, 1639\u20131650 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR136","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1002\/hep.26521","volume":"58","author":"O Morales-Ibanez","year":"2013","unstructured":"Morales-Ibanez, O.  et al. Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis. Hepatology 58, 1742\u20131756 (2013).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR137","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1056\/NEJMoa1300297","volume":"368","author":"KJ Yong","year":"2013","unstructured":"Yong, K. J.  et al. Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N. Engl. J. Med. 368, 2266\u20132276 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201535_CR138","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/ajg.2009.593","volume":"105","author":"RS O'Shea","year":"2010","unstructured":"O'Shea, R. S., Dasarathy, S. & McCullough, A. J. Alcoholic liver disease. Am. J. Gastroenterol. 105, 14\u201332 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201535_CR139","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0168-8278(01)00289-6","volume":"36","author":"P Mathurin","year":"2002","unstructured":"Mathurin, P.  et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J. Hepatol. 36, 480\u2013487 (2002).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR140","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/gut.2010.224097","volume":"60","author":"P Mathurin","year":"2011","unstructured":"Mathurin, P.  et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut 60, 255\u2013260 (2011).","journal-title":"Gut"},{"key":"BFnrgastro201535_CR141","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1136\/gut.2004.050781","volume":"54","author":"EH Forrest","year":"2005","unstructured":"Forrest, E. H.  et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut 54, 1174\u20131179 (2005).","journal-title":"Gut"},{"key":"BFnrgastro201535_CR142","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1111\/j.1572-0241.2008.02104.x","volume":"103","author":"M Dominguez","year":"2008","unstructured":"Dominguez, M.  et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am. J. Gastroenterol. 103, 2747\u20132756 (2008).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201535_CR143","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/hep.21607","volume":"45","author":"A Louvet","year":"2007","unstructured":"Louvet, A.  et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 45, 1348\u20131354 (2007).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR144","unstructured":"Centre Hospitalier Regional, Universitaire de Lille. Lille Model. LilleModel.com \n                    [online]\n                    \n                  , (2015)."},{"key":"BFnrgastro201535_CR145","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1053\/jhep.2003.09038","volume":"38","author":"P Mathurin","year":"2003","unstructured":"Mathurin, P.  et al. Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone. Hepatology 38, 1363\u20131369 (2003).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR146","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/hep.510260621","volume":"26","author":"Y Iimuro","year":"1997","unstructured":"Iimuro, Y., Gallucci, R. M., Luster, M. I., Kono, H. & Thurman, R. G. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26, 1530\u20131537 (1997).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR147","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0016-5085(99)70354-9","volume":"117","author":"M Yin","year":"1999","unstructured":"Yin, M.  et al. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 117, 942\u2013952 (1999).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR148","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S0168-8278(98)80227-4","volume":"28","author":"S Naveau","year":"1998","unstructured":"Naveau, S.  et al. Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severity. J. Hepatol. 28, 778\u2013784 (1998).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR149","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jhep.2004.04.028","volume":"41","author":"L Spahr","year":"2004","unstructured":"Spahr, L.  et al. Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis. J. Hepatol. 41, 229\u2013234 (2004).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR150","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/hep.23666","volume":"52","author":"SF Kendrick","year":"2010","unstructured":"Kendrick, S. F., Henderson, E., Palmer, J., Jones, D. E. & Day, C. P. Theophylline improves steroid sensitivity in acute alcoholic hepatitis. Hepatology 52, 126\u2013131 (2010).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR151","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/hep.24159","volume":"53","author":"AJ di Mambro","year":"2011","unstructured":"di Mambro, A. J.  et al. In vitro steroid resistance correlates with outcome in severe alcoholic hepatitis. Hepatology 53, 1316\u20131322 (2011).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR152","doi-asserted-by":"publisher","unstructured":"Dhanda, A. D.  et al. Long-term outcome in patients with severe alcoholic hepatitis can be reliably determined using an in vitro measure of steroid sensitivity. Hepatology \n                    http:\/\/dx.doi.org\/10.1002\/hep.27211\n                    \n                  .","DOI":"10.1002\/hep.27211"},{"key":"BFnrgastro201535_CR153","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1002\/hep.23572","volume":"51","author":"SF Kendrick","year":"2010","unstructured":"Kendrick, S. F.  et al. Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis. Hepatology 51, 1988\u20131997 (2010).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR154","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1002\/hep.21880","volume":"46","author":"H Hamdi","year":"2007","unstructured":"Hamdi, H.  et al. Glucocorticoid-induced leucine zipper: A key protein in the sensitization of monocytes to lipopolysaccharide in alcoholic hepatitis. Hepatology 46, 1986\u20131992 (2007).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR155","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1136\/gut.52.8.1182","volume":"52","author":"RP Mookerjee","year":"2003","unstructured":"Mookerjee, R. P.  et al. Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis. Gut 52, 1182\u20131187 (2003).","journal-title":"Gut"},{"key":"BFnrgastro201535_CR156","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S0168-8278(02)00230-1","volume":"37","author":"L Spahr","year":"2002","unstructured":"Spahr, L.  et al. Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study. J. Hepatol. 37, 448\u2013455 (2002).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR157","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0168-8278(02)00442-7","volume":"38","author":"H Tilg","year":"2003","unstructured":"Tilg, H.  et al. Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J. Hepatol. 38, 419\u2013425 (2003).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR158","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jhep.2008.10.024","volume":"50","author":"P Sharma","year":"2009","unstructured":"Sharma, P., Kumar, A., Sharma, B. C. & Sarin, S. K. Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial. J. Hepatol. 50, 584\u2013591 (2009).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR159","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/hep.20206","volume":"39","author":"S Naveau","year":"2004","unstructured":"Naveau, S.  et al. A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 39, 1390\u20131397 (2004).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR160","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","volume":"135","author":"NC Boetticher","year":"2008","unstructured":"Boetticher, N. C.,  et al. A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology 135, 1953\u20131960 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR161","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/hep.23870","volume":"52","author":"ED Brenndorfer","year":"2010","unstructured":"Brenndorfer, E. D.  et al. Anti-tumor necrosis factor alpha treatment promotes apoptosis and prevents liver regeneration in a transgenic mouse model of chronic hepatitis C. Hepatology 52, 1553\u20131563 (2010).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR162","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1053\/gast.2000.20189","volume":"119","author":"E Akriviadis","year":"2000","unstructured":"Akriviadis, E.  et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 119, 1637\u20131648 (2000).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR163","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1007\/s10620-012-2097-4","volume":"57","author":"SS Sidhu","year":"2012","unstructured":"Sidhu, S. S.  et al. Corticosteroid plus pentoxifylline is not better than corticosteroid alone for improving survival in severe alcoholic hepatitis (COPE trial). Dig. Dis. Sci. 57, 1664\u20131671 (2012).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro201535_CR164","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3748\/wjg.15.1613","volume":"15","author":"BK De","year":"2009","unstructured":"De, B. K.  et al. Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial. World J. Gastroenterol. 15, 1613\u20131619 (2009).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro201535_CR165","first-page":"192","volume":"110","author":"GM Doherty","year":"1991","unstructured":"Doherty, G. M., Jensen, J. C., Alexander, H. R., Buresh, C. M. & Norton, J. A. Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 110, 192\u2013198 (1991).","journal-title":"Surgery"},{"key":"BFnrgastro201535_CR166","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1084\/jem.172.1.391","volume":"172","author":"J Han","year":"1990","unstructured":"Han, J., Thompson, P. & Beutler, B. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin\/tumor necrosis factor synthesis at separate points in the signaling pathway. J. Exp. Med. 172, 391\u2013394 (1990).","journal-title":"J. Exp. Med."},{"key":"BFnrgastro201535_CR167","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jhep.2007.10.010","volume":"48","author":"A Louvet","year":"2008","unstructured":"Louvet, A.  et al. Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids. J. Hepatol. 48, 465\u2013470 (2008).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR168","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jama.2013.276300","volume":"310","author":"P Mathurin","year":"2013","unstructured":"Mathurin, P.  et al. Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial. JAMA 310, 1033\u20131041 (2013).","journal-title":"JAMA"},{"key":"BFnrgastro201535_CR169","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jhep.2014.05.014","volume":"61","author":"SH Park","year":"2014","unstructured":"Park, S. H.  et al. Pentoxifylline vs. corticosteroid to treat severe alcoholic hepatitis: a randomised, non-inferiority, open trial. J. Hepatol. 61, 792\u2013798 (2014).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR170","first-page":"LB1","volume":"60","author":"M Thursz","year":"2014","unstructured":"Thursz, M.  et al. Steroids or Pentoxifylline for Alcoholic Hepatitis: Results of the STOPAH Trial. Hepatology 60, LB1 (2014).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR171","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1053\/j.gastro.2010.01.040","volume":"138","author":"D Lebrec","year":"2010","unstructured":"Lebrec, D.  et al. Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis. Gastroenterology 138, 1755\u20131762 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR172","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0741-8329(02)00230-6","volume":"27","author":"CS Lieber","year":"2002","unstructured":"Lieber, C. S. S-Adenosyl-L-methionine and alcoholic liver disease in animal models: implications for early intervention in human beings. Alcohol 27, 173\u2013177 (2002).","journal-title":"Alcohol"},{"key":"BFnrgastro201535_CR173","first-page":"699","volume":"26","author":"A Colell","year":"1997","unstructured":"Colell, A.  et al. Transport of reduced glutathione in hepatic mitochondria and mitoplasts from ethanol-treated rats: effect of membrane physical properties and S-adenosyl-L-methionine. Hepatology 26, 699\u2013708 (1997).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR174","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1172\/JCI117306","volume":"94","author":"C Garcia-Ruiz","year":"1994","unstructured":"Garcia-Ruiz, C. Effect of chronic ethanol feeding on glutathione and functional integrity of mitochondria in periportal and perivenous rat hepatocytes. J. Clin. Invest. 94, 193\u2013201 (1994).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201535_CR175","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.jhep.2005.11.039","volume":"44","author":"M Phillips","year":"2006","unstructured":"Phillips, M.  et al. Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial. J. Hepatol. 44, 784\u2013790 (2006).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR176","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.jhep.2010.05.030","volume":"53","author":"C Moreno","year":"2010","unstructured":"Moreno, C.  et al. Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial. J. Hepatol. 53, 1117\u20131122 (2010).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR177","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jhep.2007.03.027","volume":"47","author":"S Stewart","year":"2007","unstructured":"Stewart, S.  et al. A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis. J. Hepatol. 47, 277\u2013283 (2007).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR178","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","volume":"365","author":"E Nguyen-Khac","year":"2011","unstructured":"Nguyen-Khac, E.  et al. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N. Engl. J. Med. 365, 1781\u20131789 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201535_CR179","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/hep.23264","volume":"50","author":"T Gustot","year":"2009","unstructured":"Gustot, T., Durand, F., Lebrec, D., Vincent, J. L. & Moreau, R. Severe sepsis in cirrhosis. Hepatology 50, 2022\u20132033 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201535_CR180","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","volume":"137","author":"A Louvet","year":"2009","unstructured":"Louvet, A.  et al. Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor. Gastroenterology 137, 541\u2013548 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR181","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jhep.2004.10.019","volume":"42","author":"HE Wasmuth","year":"2005","unstructured":"Wasmuth, H. E.  et al. Patients with acute on chronic liver failure display \u201csepsis-like\u201d immune paralysis. J. Hepatol. 42, 195\u2013201 (2005).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR182","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s11095-008-9571-x","volume":"25","author":"CG Leon","year":"2008","unstructured":"Leon, C. G., Tory, R., Jia, J., Sivak, O. & Wasan, K. M. Discovery and development of toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases. Pharm. Res. 25, 1751\u20131761 (2008).","journal-title":"Pharm. Res."},{"key":"BFnrgastro201535_CR183","doi-asserted-by":"publisher","first-page":"299","DOI":"10.7326\/0003-4819-113-4-299","volume":"113","author":"TF Imperiale","year":"1990","unstructured":"Imperiale, T. F. & McCullough, A. J. Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. Ann. Intern. Med. 113, 299\u2013307 (1990).","journal-title":"Ann. Intern. Med."},{"key":"BFnrgastro201535_CR184","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","volume":"75","author":"WC Maddrey","year":"1978","unstructured":"Maddrey, W. C.  et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75, 193\u2013199 (1978).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201535_CR185","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-230X-13-55","volume":"13","author":"T Hardy","year":"2013","unstructured":"Hardy, T.  et al. White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers. BMC Gastroenterol. 13, 55. (2013).","journal-title":"BMC Gastroenterol."},{"key":"BFnrgastro201535_CR186","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.jhep.2011.02.021","volume":"55","author":"RP Mookerjee","year":"2011","unstructured":"Mookerjee, R. P.  et al. The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis. J. Hepatol. 55, 1103\u20131111 (2011).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201535_CR187","unstructured":"US National Library of Medicine, ClinicalTrials.gov \n                    [online]\n                    \n                  , (2015)."},{"key":"BFnrgastro201535_CR188","unstructured":"US National Library of Medicine, ClinicalTrials.gov \n                    [online]\n                    \n                  , (2014)."},{"key":"BFnrgastro201535_CR189","unstructured":"US National Library of Medicine, ClinicalTrials.gov \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrgastro201535_CR190","unstructured":"US National Library of Medicine, ClinicalTrials.gov \n                    [online]\n                    \n                  , (2014)."},{"key":"BFnrgastro201535_CR191","unstructured":"US National Library of Medicine, ClinicalTrials.gov \n                    [online]\n                    \n                  , (2014)."},{"key":"BFnrgastro201535_CR192","unstructured":"US National Library of Medicine, ClinicalTrials.gov \n                    [online]\n                    \n                  , (2014)."},{"key":"BFnrgastro201535_CR193","unstructured":"US National Library of Medicine, ClinicalTrials.gov \n                    [online]\n                    \n                  , (2014)."},{"key":"BFnrgastro201535_CR194","unstructured":"US National Library of Medicine, ClinicalTrials.gov \n                    [online]\n                    \n                  , (2014)."},{"key":"BFnrgastro201535_CR195","unstructured":"US National Library of Medicine, ClinicalTrials.gov \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrgastro201535_CR196","unstructured":"US National Library of Medicine, ClinicalTrials.gov \n                    [online]\n                    \n                  , (2014)."},{"key":"BFnrgastro201535_CR197","unstructured":"US National Library of Medicine, ClinicalTrials.gov \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrgastro201535_CR198","unstructured":"US National Library of Medicine, ClinicalTrials.gov \n                    [online]\n                    \n                  , (2014)."},{"key":"BFnrgastro201535_CR199","unstructured":"US National Library of Medicine, ClinicalTrials.gov \n                    [online]\n                    \n                  , (2014)."},{"key":"BFnrgastro201535_CR200","unstructured":"US Department of Health and Human Services. NIH Research Portfolio Online Report Tools (RePORT) \n                    [online]\n                    \n                  , (2015)."}],"container-title":["Nature Reviews Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2015.35","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2015.35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2015.35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:53:46Z","timestamp":1684454026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2015.35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,17]]},"references-count":200,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["BFnrgastro201535"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2015.35","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,17]]},"assertion":[{"value":"17 March 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}